Management of the anophthalmic socket in pediatric patients

Current Opinion in Ophthalmology

Volumn 15, Issue 5, 2004, Pages 449-453

  Chen, David ^a,b,c   Heher, Katrinka ^a,b  

^a TUFTS UNIVERSITY   (United States)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NONE   (United States)

Author keywords

Anophthalmia; Conformers; Enucleation; Evisceration; Orbit reconstruction; Orbital expanders; Orbital implants

Indexed keywords

HYDROXYAPATITE; POLY(METHYL METHACRYLATE); POLYETHYLENE;

ANOPHTHALMIA; CHILD; DERMIS; DEVICE; ENUCLEATION; EVISCERATION; EYE PATCHING; HUMAN; ORBIT IMPLANT; ORBIT RECONSTRUCTION; PEDIATRICS; PRIORITY JOURNAL; REVIEW; SURGICAL PATIENT; TISSUE EXPANSION;

ANOPHTHALMOS; CHILD; CHILD, PRESCHOOL; EYE ENUCLEATION; EYE EVISCERATION; HUMANS; INFANT; ORBIT; ORBITAL IMPLANTS; TISSUE EXPANDERS; TISSUE EXPANSION;

EID: 4644293268     PISSN: 10408738     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.icu.0000137855.45573.02     Document Type: Review

References (57)

1. Fantes J, Ragge NK, Lynch SA, et al.: Mutations in SOX2 cause anophthalmia. Nat Genet 2003, 33:461-463. Gene analysis of some patients with bilateral anophthalmia showed mutation in the SOX2 gene.
2. Demirci H, Singh AD, Shields JA, et al.: Bilateral microphthalmos and orbital cyst. Eye 2003, 17:273-276. Clinical and histopathologic findings in a patient with bilateral microphthalmos and orbital cyst with no associated systemic abnormalities.
3. Erie JC, Nevitt MP, Hodge D, et al.: Incidence of enucleation in a defined population. Am J Ophthalmol 1992, 113:138-144.
4. Dunn ES, Jaeger EA, Jeffers JB, et al.: The epidemiology of ruptured globes. Ann Ophthalmol 1992, 24:405-410.
5. Margo CE: Surgical enucleation in community hospitals. Am J Ophthalmol 1989, 108:452-453.
6. Spraul C, Grossniklaus H: Analysis of 24,444 surgical specimens accessioned over 55 years in an ophthalmic pathology laboratory. Int J Ophthalmol 1997-98, 21:283-304
7. Moshfeghi DM, Moshfeghi AA, Finger PT: Enucleation. Survey Ophthalmol 2000, 44:277-301.
8. Christmas NJ, Quill KV, Murray TG, et al.: Evaluation of efficacy and complications: primary pediatric orbital implants after enucleation. Arch Ophthalmol 2000, 118:503-506.
9. Mitchell KT, Hollsten DA, White WL, et al.: The autogenous dermis-fat orbital implant in children. J Am Assoc Pediatr Ophthalmol Strab 2001, 5:367-369.
10. Nolan LM, O'Keefe M, Lanigan B: Hydroxyapatite orbital implant exposure in children. J Am Assoc Pediatr Opthalmol Strab 2003, 7:345-348. High rate of conjunctival erosion and subsequent implant exposure was reported in this case series.
11. Canning CR, McCartney AC, Hungerford J: Medulloepithelioma (diktyoma). Br J Ophthalmol 1988, 72:764-767.
12. Wong TY, Seet MB, Ang CL: Eye injuries in twentieth century warfare: a historical perspective. Surv Ophthalmol 1965, 60:1106-1109.
13. Beard CH: Enucleation. In Ophthalmic Surgery. Philadelphia: P. Blakiston's Son & Co. 1910: 457-477.
14. Mules PH: Evisceration of the globe, with artificial vitreous. Trans Ophthalmol Soc U K 1885, 5:200.
15. Timothy NH, Freilich DE, Linberg JV: Evisceration versus enucleation from the ocularist's perspective. Ophthal Plast Reconstr Surg 2003, 19:417-420. Survey showing that the ocularists overwhelmingly reported better ocular motility in patients with evisceration than those with enucleation.
16. Dortzbach RK, Wog JJ: Choice of procedure: enucleation, evisceration, or prosthetic fitting over globe. Ophthalmology 1985, 92:1249-1255.
17. Walter WL: Update on enucleation and evisceration surgery. Ophthal Plast Reconstr Surg 1985, 1:243-252.
18. Migliori ME: Enucleation versus evisceration. Curr Opin Ophthalmol 2002, 13:298-302.
19. Burroughs JR, Soparkar CN, Patrinely JR, et al.: Monitored anesthesia care for enucleation and evisceration. Ophthalmology 2003, 110:311-313. Case series reported successful use of monitored anesthesia care for enucleation and eviscerations.
20. Soros P, Vo O, Husstedt IW, et al.: Phantom eye syndrome: its prevalence, phenomenology, and putative mechanisms. Neurol 2003, 60:1542-1543. Clinical characteristic and possible mechanisms of phantom eye syndrome are discussed.
21. Isenberg SJ, ed: The Eye in Infancy. Chicago: Year Book Medical Publishers; 1989:31-36.
22. Farkas LG, Posnick JC, Hreczko TM, et al.: Growth patterns in the orbital region: a morphometric study. Cleft Palate-Craniofac J 1992, 29:315-318.
23. Nunery WR, Heinz GW, Bonnin JM, et al.: Exposure rate of hydroxyapatite spheres in the anophthalmic socket: histopathologic correlation and comparison with silicons sphere implants. Ophthal Plast Reconstr Surg 1993, 9:96-104.
24. Li T, Shen J, Duffy MT: Exposure rates of wrapped and unwrapped orbital implants following enucleation. Ophthal Plast Reconstr Surg 2001, 17:431-435.
25. Buettner H, Bartley. Tissue breakdown and exposure associated with orbital hydroxyapatite implants. Am J Ophthalmol 1992, 113:669-673.
26. Aral YO, Shetlar DJ, Boniuk M: Bovine pericardium versus homologous sclera as a wrapping for hydroxyapatite orbital implants. Ophthal Plast Reconstr Surg 2003, 19:189-193. High implant exposure rates are reported with the use of bovine pericardium as a wrapping material.
27. Bidar M, Hawes MJ, Dresner SC, et al.: Conjunctival melting syndrome associated with the use of bovine pericardium wrapping material. Ophthal Plast Reconstr Surg 2003, 19:256-261. High rate of conjunctival breakdown is reported when bovine pericardium is used as wrapping material for orbital implants.
28. Jordan DR, Klapper SR, Gilberg SM: The use of Vicryl mesh in 200 porous orbital implants. Ophthal Plast Reconstr Surg 2003, 19:53-61. Case series using Vicryl mesh as wrapping material for porous orbital implants.
29. rd, et al.: Enucleation: is wrapping the implant necessary for optimal motility? Ophthal Plast Reconstr Surg 2003, 19:194-197. Randomized study showing no difference in motility between wrapped and unwrapped hydroxyapatite implants after enucleation at 6 weeks.
30. Jordan DR, Brownstein S, Dorey MW: One patient with infection at different times of 2 hydroxyapatite implants, each requiring explantation. Can J Ophthalmol 2003, 38:406-409. Case report of infections associated with the hydroxyapatite implant.
31. You JR, Seo JH, Kim YH, et al.: Six cases of bacterial infection in porous orbital implants. Jap J Ophthalmol 2003, 47:512-518. Case reports of bacterial infections that developed in hydroxyapatite orbital implants.
32. Custer PL, Kennedy RH, Woog JJ, et al.: Orbital implants in enucleation surgery: a report by the American Academy of Ophthalmology. Ophthalmology 2003, 110:2054-2061. Excellent review article evaluating published reports of prosthetic and implant motility, and complications associated with porous and nonporous orbital implants.
33. Colen TP, Paridaens DA, Lemij HG, et al.: Comparison of artificial eye amplitudes with acrylic and hydroxyapatite spherical enucleation implants. Ophthalmology 2000, 107:1889-1894.
34. Guillinta P, Vasani SN, Granet DB, et al.: Prosthetic motility in pegged versus unpegged integrated porous orbital implants. Ophthal Plast Reconstr Surg 2003, 19:119-122. Prospective case series reporting improved horizontal gaze after motility peg placement.
35. Gilliland GD, Trawnik R, Harrington JN: Improved prosthetic motility with placement of a second coupling peg. Ophthal Plast Reconstr Surg 2003, 19:123-127. Case series showing improved prosthetic motility with the placement of a second motility coupling peg.
36. Klapper SR, Jordan DR, Ells A, et al.: Hydroxyapatite orbital implant vascularization assessed by magnetic resonance imaging. Ophthal Plast Reconstr Surg 2003, 19:46-52. MRI was used to assess the time for fibrovascular ingrowth in orbital implants.
37. Nunery WR, Heinz GW, Bonnin JM, et al.: Exposure rate of hydroxyapatite sphere in the anophthalmic socket: histopathologic correlation and comparison with silicone implants. Ophthal Plast Reconstr Surg 1993, 9:96-104.
38. Jordan DR, Gilsberg S, Bawazeer A: Coralline hydroxyapatite orbital implant (bio-eye); experience with 158 patients. Ophthal Plast Reconstr Surg 2003, 20:69-74. Complications associated with coralline hydroxyapatite orbital implant (bio-eye) are discussed in this case series.
39. Jordan DR, Gilberg S, Mawn LA: The bioceramic orbital implant: experience with 107 implants. Ophthal Plast ReconstrSurg 2003, 19:128-135. Complications associated with bioceramic orbital implant (aluminum oxide) are discussed in this case series.
40. Blaydon SM, Shepler TR, Neuhaus RW, et al.: The porous polyethylene (Medpor) spherical orbital implant: a retrospective study of 136 cases. Ophthal Plast Reconstr Surg 2003, 19:364-371. Complications associated with porous polyethylene (Medpor) spherical orbital implant are discussed in this case series.
41. Fay A, Rubin PA: Letter to editor. Ophthalmology 2003, 110: 1282. Editorial comment on surgical technique to decrease orbital implant exposure.
42. Katowitz JA. Orbital expansion with dermis-fat grafts in the pediatric age group. Presented at the annual meeting of the American Academy of Ophthalmology, Anaheim, California, October 14, 1991.
43. Heher K, Katowitz J, Low J. Unilateral dermis-fat implantation in the pediatric orbit. Ophthal Plast Reconstr Surg 1998, 14:81-88.
44. Oberhansli C, Charles-Messance D, Munier F, et al.: Management of microphthalmos and anophthalmos: prosthetic experience. Kinische Monatblatter fur Augenheilkunde 2003, 220:134-137. The authors advocate using conformers to encourage socket growth in patients with microphthalmos and anophthalmos.
45. McLean CJ, Ragge NK, Jones RB, Collin JRO: The management of orbital cysts associated with congenital microphthalmos and anophthalmos. Br J Ophthalmol 2003, 87:860-863. Excellent retrospective study with guidelines for the management of orbital cysts associated with congenital microphthalmos and anophthalmos.
46. Osborne D, Madden B, Deeming LW: Orbital growth after childhood enucleation. Am J Ophthalmol 1974, 77:756-759.
47. Kennedy RE: The effect of early enucleation on the orbit in animals and humans. Am J Ophthalmol 1965, 60:277-306.
48. Kiskadden WS, McDowell AJ, Keiser T: Results of early treatment of congenital anophthalmos. Plast Reconstr Surg 1949, 4:426-433.
49. Grossman MD, Mohay J, Roberts DM: Expansion of the human microphthalmic orbit. Ophthalmology 1999, 106:2005-2009.
50. Lee-Wing MW: Amniotic membrane for repair of exposed hydroxyapatite orbital implant. Ophthal Plast Reconstr Surg 2003, 19:401-402. Case report of using amniotic membrane graft to repair exposed hydroxyapatite orbital implant.
51. Inkster CF, Ng SG, Leatherbarrow B: Primary banked scleral patch graft in the prevention of exposure of hydroxyapatite orbital implants. Ophthalmology 2002, 109:389-392.
52. Salour H, Owji N, Farahi A: Two-stage procedure for management of large exposure defects of hydroxyapatite orbital implant. Eur J Ophthalmol 2003, 13:789-793. Surgical approach to repair large exposure defects by first closing the primary defect and then reconstructing the shortened fornix by mucous membrane or dermis-fat grafts.
53. Ito O, Suzuki S, Parks S, et al.: Usefulness of palatal mucoperiosteal graft for artificial eye socket contracture. Ann Plast Surg 2003, 51:278-282. Case series using palatal mucoperiosteal graft to reconstruct contracture of the anophthalmic socket.
54. O'Keefe M, Webb M, Pashby RC, et al.: Clinical anophthalmos. Br J Ophthalmol 1987, 71:635-822.
55. Marchac D, Cophignon J, Achard E, et al.: Orbital expansion for anophthalmia and micro-orbitism. Plast Reconstr Surg 1977, 59:486-491.
56. Adenis JP, Camezind P, Petit B, et al.: Bone formation in hydroxyapatite tricalcium phosphate ceramic implants used in the treatment of postenucleation socket syndrome. Orbit 2003, 22:183-191. Histopathologic changes in the coralline hydroxyapatite tricalcium phosphate blocks removed after complications from treatment of postenucleation socket syndrome.
57. Kaltreider SA, Shields MD, Hippeard SC, et al.: Anophthalmic ptosis: investigation of the mechanisms and statistical analysis. Ophthal Plast Reconstr Surg 2003, 19:421-428. Comparative study showing that anophthalmic ptosis was more likely in patients with volume deficiency, secondary implants, and increased years of prosthetic wear.